Skip to main content
Premium Trial:

Request an Annual Quote

Still a Reason to Party

At the New York Times, Olivia Judson pauses before even beginning the soon-to-come celebrations for 150th anniversary of the theory of natural selection and the 200th birthday of Charles Darwin to discuss if Darwin merits such revelry. Darwin was neither the first to posit that evolution occurs, nor was he the first to discuss natural selection, nor was he always right — he did a fair bit of editing in his time. He was, though, the one to support these ideas with vast amounts of evidence, and communicate them well. "His knowledge of the natural world is so immense, and the scrutiny to which he subjects his ideas is so thorough and scrupulous, that the 'Origin' presents a grand new vision of the world," blogs Judson.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.